Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Ender

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Allergy and Clinical Immunology|October 19, 2023
ReplyKelley Dages, Elizabeth Ender, Miguel Park, et al.
Vaccine|December 12, 2024
Seroconversion following PPSV23 vaccination in children with type 1 diabetes mellitusElizabeth Ender, Avni Joshi, Melissa Snyder, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 13, 2022
Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal AntibodiesJohn B Hagan, Elizabeth Ender, Rohit D Divekar, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Allergy and Clinical Immunology|October 19, 2023
ReplyKelley Dages, Elizabeth Ender, Miguel Park, et al.
Vaccine|December 12, 2024
Seroconversion following PPSV23 vaccination in children with type 1 diabetes mellitusElizabeth Ender, Avni Joshi, Melissa Snyder, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 13, 2022
Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal AntibodiesJohn B Hagan, Elizabeth Ender, Rohit D Divekar, et al.
Pageof 1